ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional Results available

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

ClinicalTrials.gov ID: NCT05305040

Public ClinicalTrials.gov record NCT05305040. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ALVR105 Posoleucel (ALVR105,Viralym-M) Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCV Infection and/or Disease, in High-Risk Patients After Allogeneic Hematopoietic Cell Transplant

Study identification

NCT ID
NCT05305040
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
AlloVir
Industry
Enrollment
451 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 23, 2022
Primary completion
Jan 29, 2024
Completion
Jan 29, 2024
Last update posted
May 15, 2024

2022 – 2024

United States locations

U.S. sites
35
U.S. states
26
U.S. cities
34
Facility City State ZIP Site status
University of Alabama at Birmingham Children's of Alabama Birmingham Alabama 35233
Honor Health Research Institute Scottsdale Arizona 85258
City of Hope Duarte California 91010
University of California, Los Angeles (UCLA) Los Angeles California 90095
Stanford University Palo Alto California 94304
University of California San Francisco - Benioff Children's Hospital San Francisco California 94143
University of Colorado Hospital Aurora Colorado 80045
Yale University School of Medicine - Yale Cancer Center New Haven Connecticut 06520
Childrens National Health System Washington D.C. District of Columbia 20010
University of Florida (UF) - Gainesville Gainesville Florida 32610
Moffitt Cancer Center Tampa Florida 33612
Northside Hospital Atlanta Georgia 30342
Loyola University Medical Center Maywood Illinois 60153
Indiana University Hospital Simon Comprehensive Cancer Center Indianapolis Indiana 46202
University of Kansas Hospital Kansas City Kansas 66160
University of Maryland Baltimore Maryland 21201
Dana-Farber Cancer Institute Boston Massachusetts 02215
University of Minnesota Minneapolis Minnesota 55455
Children's Mercy Hospital Kansas City Missouri 64108
Washington University School of Medicine St Louis Missouri 63110
Hackensack University Medical Center Hackensack New Jersey 07601
Roswell Park Cancer Institute Buffalo New York 14263
Columbia University New York New York 10032
Weill Cornell Medical College New York New York 10065
Stony Brook University Hospital Cancer Center Stony Brook New York 11794
Carolinas Medical Center/Levine Charlotte North Carolina 28203
Nationwide Children's Hospital Columbus Ohio 43205
Oregon Health & Science University Portland Oregon 97239
University of Pennsylvania Philadelphia Pennsylvania 19104
Children's Medical Center Dallas Dallas Texas 75235
University of Utah/Primary Childrens Hospital Salt Lake City Utah 84113
University of Virginia Charlottesville Virginia 22908
Virginia Commonwealth University Richmond Virginia 23298
Fred Hutchinson Cancer Research Center Seattle Washington 98109
Froedtert Hospital and the Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05305040, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 15, 2024 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05305040 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →